Ernest Mario Joins the Board of Delpor, Inc.
Delpor continues to strengthen its expertise in drug delivery with the addition of the former CEO of Glaxo and Alza to its Board of Directors. SAN FRANCISCO, CA, January 19, [...]
Delpor, Inc. Announces Scientific Advisory Board with Experts in Psychiatry and Drug Delivery
Panel of internationally renowned researchers and clinicians will guide development of Delpor’s drug delivery based products in schizophrenia, hepatitis C, diabetes, and other diseases. SAN FRANCISCO, CA, July 13, 2011 [...]
Delpor, Inc. Announces Issuance of Nanopore Drug Delivery Patent
Nanopore technology enables the sustained release of drugs during several months from a small subcutaneous implant device. SAN FRANCISCO, CA, June 23, 2011 – Delpor, Inc. (Delpor), a biotechnology company [...]